Russia says India approves one-shot Sputnik Light COVID vaccine

1 minute read

A view shows vials with the one-dose Sputnik Light vaccine against the coronavirus disease (COVID-19) in a vaccination centre at a city market in Moscow, Russia, June 30, 2021. REUTERS/Tatyana Makeyeva

Register now for FREE unlimited access to Reuters.com

MOSCOW, Feb 6 (Reuters) - India has given regulatory approval to Russia's one-shot Sputnik Light COVID-19 vaccine after it authorized Russia's main vaccine - the two-dose Sputnik V - last year, the Russian Direct Investment Fund said on Sunday.

Sputnik Light, the first component of the Sputnik V vaccine, can be used as a booster shot with other vaccines, RDIF said.

Head of the fund Kirill Dmitriev called Sputnik Light in a statement "the solution to increase efficacy and duration of other vaccines, including against Omicron variant".

RDIF struck deals with seven Indian pharmaceutical companies to make a total of 1 billion Sputnik doses both for export and for use in India. read more

Register now for FREE unlimited access to Reuters.com
Reporting by Andrew Osborn, writing by Maria Tsvetkova, editing by Alexander Smith and Catherine Evans

Our Standards: The Thomson Reuters Trust Principles.